You are here: Industry Insights > CDMO

News List

Lonza to invest in mid-scale API manufacturing expansion at Chinese facility cphi-online
June 30, 2021
The expansion of mid-scale capacity will enable the company to offer a smooth transition between early-phase and large-scale commercial production.
WuXi STA to build second US pharma manufacturing site at Middletown cphi-online
June 30, 2021
Facility is expected to come online in 2024 and will feature testing laboratories, manufacture of active pharmaceutical ingredients and manufacture and packaging of solid dosage pharmaceuticals and sterile products.
Genezen begins construction of cGMP lentiviral production facility cphi-online
June 28, 2021
Genezen has made a start on turning its new multiphase master plan for a 75,000-sq. ft cGMP-compliant lentiviral vector production facility into reality.
CPhI Monthly Podcast: M&A strategies in the CDMO sector cphi-online
June 28, 2021
This month we discuss what is driving M&A strategies in the pharma space, paying particular attention to how investors regard the potential for the growing but fragmented CDMO sector
ProBioGen and LAVA Therapeutics sign cell line development agreement cphi-online
June 24, 2021
The agreement marks the second cell line development collaboration between the two companies
Procaps Group Announces Filing of Registration Statement on Form F-4 in Connection With its Proposed Business Combination with Union Acquisition Corp. II firstwordpharma
June 22, 2021
Procaps Group today announced the filing of a registration statement on Form F-4 (the "Registration Statement"), which contains a preliminary proxy statement/prospectus, with the U.S. Securities and Exchange Commission ("SEC")
Recro Expands Board of Directors contractpharma
June 17, 2021
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving formulation and manufacturing challenges for companies developing oral solid dose drug products, has appointed Laura L. Parks, Ph.D., to the company’s ...
Mikart Expands Oral Solids Production Capabilities contractpharma
June 16, 2021
Mikart, a pharmaceutical contract development and manufacturing organization (CDMO), has acquired a state-of-the-art Korsch XM12 to meet their pharmaceutical client demands for complex formulation development and production of oral solid dose products.
Vibalogics invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors firstwordpharma
June 10, 2021
Vibalogics, a global contract development and manufacturing organization (CDMO), has today announced that it has initiated the first stage of a planned $50 million dollar investment at its Cuxhaven, Germany facility, expanding early-to-late phase clinical
MedPharm expands topical and transdermal delivery services cphi-online
June 03, 2021
A new location in Raleigh-Durham, North Carolina, close to the CDMO's Center of Excellence, will double its current footprint

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page